60 stories tagged with #pharmaceuticals, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Pharmaceuticals"
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Amylyx Pharmaceuticals, Inc. (AMLX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 10:40 AM EDTCompany ParticipantsJustin Klee -...…
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call June 10, 2026 11:00 AM EDTCompany ParticipantsJoseph Oliveto - CEO, President & Executive...…
Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Ionis Pharmaceuticals, Inc. (IONS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 8:40 AM EDTCompany ParticipantsBrett Monia -...…
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Andrew Left faces 20 years in prison — but having a correct opinion about a stock shouldn’t be a crime
Prosecutors alleged Left circulated his research on social media and financial TV to move a bunch of stocks and make a ton of money.…
Form 144 XENON PHARMACEUTICALS INC For: 5 June
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Tenaya Therapeutics, Inc. (TNYA) Jefferies Global Healthcare Conference 2026 June 4, 2026 3:10 PM EDTCompany ParticipantsFaraz Ali - CEO, Interim Principal...…
Replimune: Modeling The Coin Flip Of FDA Approval
Replimune (REPL) faces a binary FDA decision on RP1 in advanced melanoma. RP1 approval could push REPL to $14.99/share. See more here.…
Exelixis, Inc. (EXEL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Exelixis, Inc. (EXEL) Jefferies Global Healthcare Conference 2026 June 3, 2026 11:05 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President of...…
Telix Pharmaceuticals Limited (TLX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
2026-06-03. The following slide deck was published by Telix Pharmaceuticals Limited in conjunction with this event.…
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jazz Pharmaceuticals plc (JAZZ) Jefferies Global Healthcare Conference 2026 June 3, 2026 10:30 AM EDTCompany ParticipantsRobert Iannone - Executive VP,...…
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis Transcript
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis June 2, 2026 2:00 PM EDTCompany...…
U.S. FDA issues VAI classification to Granules arm Virginia facility
U.S. FDA classifies Granules Pharmaceuticals' Virginia facility with VAI status, indicating found issues but no immediate regulatory action.…
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call June 3, 2026 12:00 PM EDTCompany ParticipantsKevin Tang - Chairman & CEOStephen P.…
U.S. FDA issues warning letter to Zydus Lifesciences’ Baddi formulation unit
The U.S. Food and Drug Administration (U.S. FDA) has issued a warning letter to Zydus Lifesciences relating to the company’s formulation manufacturing facility in Baddi, Himachal P…
Form 144 RECURSION PHARMACEUTICALS For: 3 June
Legend Biotech Jumps 42% On New Data -- Here's What Comes Next
Buy Legend Biotech (LEGN): new Carvykti CARTITUDE-4 data show better survival and <1% Parkinsonism; upside at 3.0x EV/sales—read now.…
Milestone Pharmaceuticals: Taking The Long View
Milestone Pharma (MIST) stays a Hold after Q1 misses and a tough CARDAMYST launch; PSVT pricing, uptake, and payer risk loom.…
Astellas Pharma Inc. (ALPMY) Discusses Corporate Strategic Plan and Vision for Value-Based Healthcare - Slideshow
2026-06-03. The following slide deck was published by Astellas Pharma Inc.…
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.…
To fight the drug affordability crisis, Trump must crack down on middlemen
Although Trump is taking steps to investigate insurer and PBM practices, it's time for him to crack down on these bad actors once and for all.…
Rhythm Pharmaceuticals stock rating reaffirmed by Citizens
STEPHEN MOORE: Foreign drug price controls are a hidden tax on Americans
The U.S. pays more for drugs because foreign governments cap prices, creating trade distortions that shift pharmaceutical costs onto Americans.…
Roche Holding AG (RHHBY) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026 - Slideshow
2026-06-03. The following slide deck was published by Roche Holding AG in conjunction with this event.…
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.…
Exclusive: Apoha, a startup building AI models for creating new materials, emerges from stealth with $36 million Series A funding round
VC firm Singular is leading the round for Apoha, which is targeting pharmaceutical and food industry for its 'liquid intelligence.'…
Rhythm Pharmaceuticals: The Rare Obesity Platform Is Becoming A Commercial Engine
Rhythm Pharma (RYTM) growth outlook: IMCIVREE approvals for hypothalamic obesity, rapid uptake, catalysts, and pipeline. See more details here.…
MannKind At An Inflection Point: Pediatric Expansion Drives The Story
MannKind’s Afrezza wins FDA approval for pediatric use—unlocking growth and a $300–500M opportunity. Read here for more on MNKD stock.…
Madrigal Pharmaceuticals Could Become The Next Vertex
Madrigal stock buy thesis: Rezdiffra leads MASH as TAM expands; growth for 2–3 years but big competition risks. Click for more on MDGL here.…
Form 144 AURINIA PHARMACEUTICALS INC. For: 2 June
Treatment for millions of Americans at stake in ‘skinny label’ Supreme Court case
The Supreme Court will soon decide a case that could upend the balance built into a bipartisan law that has accelerated the launch of generic drugs and saved American patients, emp…
Pharvaris N.V. (PHVS) Presents at The 2026 Eastern Allergy Conference - Slideshow
2026-05-30. The following slide deck was published by Pharvaris N.V.…
Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside
Q1 results show U.S. generic erosion hitting Entresto/Promacta sales, limited upside at current valuation, and patent-cliff risks.…
Form 13G Eloxx Pharmaceuticals For: 29 May
MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript
MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older May 29, 2026 4:30 PM EDTCompany...…
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class
Agios Pharmaceuticals, Inc. a Sell amid tebapivat setback & tougher PK activator competition; see risks, SCD catalysts, and cash runway. Click for an AGIO update.…
Form 6K Eupraxia Pharmaceuticals Inc For: 29 May
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 29 May
Guselkumab Adds PsA Structural Damage Inhibition to Label
Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.…
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Vertex Pharmaceuticals Incorporated (VRTX) Bernstein 42nd Annual Strategic Decisions Conference May 29, 2026 9:00 AM EDTCompany ParticipantsReshma...…
Huge haul of weight-loss drugs seized in Northampton country estate
Two men arrested in raid in which 12,000 doses of unlicensed weight-loss medicines were recovered…
Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
Atea Pharmaceuticals, Inc. gets a Buy ahead of mid-2026 phase 3 HCV data. Click here to read in detail about the AVIR stock.…
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.…
Weekly Dose of Optimism #195
LDL Gene Therapy, GLP-1s slow Cancer, Supersonic Hermeus, Nanotech, Moon Base + Extra Doses…
Cantor Fitzgerald raises ARS Pharmaceuticals stock price target on CSU program potential
Hemogenyx Pharmaceuticals grants options, extends warrants
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.…
The View’s Joy Behar Is Furious TrumpRX Is Lowering Drug Costs
One day, historians may look back at The View and conclude the program functioned less as political commentary and more as accidental satire. That conclusion became even more plaus…
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.…
Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Eli Lilly and Company (LLY) Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 1:30 PM EDTCompany ParticipantsDaniel Skovronsky - Chief...…
Rigel Pharmaceuticals director Ali-Jackson Kamil sells $72,925 in stock
Form 144 Eton Pharmaceuticals For: 28 May
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment May 28, 2026 10:00 AM EDTCompany ParticipantsConstantin Fest -...…
Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
Ionis Pharmaceuticals remains a Buy, with a compelling bull case despite a >125% 12-month share price increase. Read more on IONS stock here.…
Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSX
Toronto company founded by the late Barry Sherman expected to become Canada’s most valuable public life sciences company…
Apogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended Dosing
Apogee Therapeutics, Inc. rated Buy: zumilokibart Phase 2b AD results, 2–4 doses/yr, Blackstone $1.3B funding; fair value $82.97—read now. Click for an APGE update.…
STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, …
Form 144 KalVista Pharmaceuticals For: 27 May
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript
Jazz Pharmaceuticals plc (JAZZ) TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA May 27, 2026 2:00 PM EDTCompany...…